My watch list  

74 Current news from israel

matching the following criteria

Merck Invests in Research Partnerships in Israel to Boost Innovation


Merck is increasingly counting on partnerships with Israeli biotech companies, as demonstrated by its cooperation with Metabomed and ChanBio, both of which joined the Merck Serono Israel Bioincubator now. Merck is already cooperating with multiple Israeli start-up companies such as Qlight ...


D-Pharm Commences Phase 2 Study with THR-18 In Stroke Patients Treated with Tissue Plasminogen Activator


D-Pharm Ltd announced receipt of approval from the regulatory authorities in the Ukraine to commence a Phase IIa clinical study of THR-18, to be given with the clot buster drug tissue plasminogen activator (tPA), in patients with acute ischemic stroke. THR-18 is a synthetic therapeutic peptide ...


Evogene reports first quarter 2013 financial results


Evogene Ltd. (EVGN) announced its financial results for the first quarter ended March 31, 2013. Revenues for the first quarter of 2013 grew to $4.6 million, compared to $4.2 million for the same period in 2012. Evogene’s current revenues consist primarily of research and licensing revenues ...


'Traffic' in our cells works both for and against us


A mechanism that permits essential substances to enter our cells while at the same time removing from them harmful components also has a "down side." This negative aspect prevents vital drugs, such as anti-cancer drugs, from achieving their designed functions, while also enabling bacterial cells ...


Researchers from BGU have generated a promising drug candidate for the treatment of Psoriasis


Researchers from the Department of Life Sciences and the National Institute for Biotechnology in the Negev at Ben-Gurion University of the Negev in collaboration with Teva pharmaceutical industries LTD. have engineered a natural immune system receptor into a promising drug candidate for the ...


PolyPid announces positive preliminary results of clinical trial with BonyPid


PolyPid Ltd. announced positive preliminary results of a first-in-man clinical trial with its BonyPid™ product. BonyPid™ is a combined drug and medical device product integrating bone filler and a substantial antibiotic release platform. The bone filler is resorbed and replaced by the bone during ...


Aspireo Receives Positive Opinion from EMA for Orphan Disease Designation for Somatoprim


Aspireo Pharmaceuticals Limited announced that the Committee for Orphan Medicinal Products (COMP) at the European Medicines Agency (EMA) has issued a positive opinion on an application for orphan medicinal product status for Aspireo’s Somatoprim (DG3173) for the treatment of acromegaly.The ...


WITec appoints new distributor in Israel

Advanced Technological Solutions Ltd. selected as exclusive representative


WITec, worldwide leader in nano-analytical microscopy systems, has appointed Advanced Technological Solutions Ltd. (ATSL) as its exclusive distributor in Israel. From now on ATSL will support WITec’s market entry and promote the full product line of high-resolution SNOM, AFM and Raman Imaging ...


Gene Silencing biotechnology developed at BGU to advance Vietnamese Aquaculture


Prof. Amir Sagi from Ben-Gurion University of the Negev (BGU) participated in a ceremony marking the realization of an agreement between the Israeli Tiran Group and Green Advances, a Vietnamese company, to advance aquaculture in Vietnam using BGU biotechnology to change the sex of prawns and ...


Ben-Gurion University of the Negev’s Dr. Raz Zarivach named as EMBO Young Investigator


r. Raz Zarivach of the Department of Life Sciences and a member of the National Institute for Biotechnology in the Negev was recently declared an EMBO Young Investigator. He is one of four Israelis to receive this honor among a group of 22 young researchers from around the world. Zarivach is ...


Page 1 From 8
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE